跳至主要内容
临床试验/PACTR202006534973105
PACTR202006534973105已完成1 期

Measurement of serum soluble CD4 levels in patients with external anogenital warts before and after intralesional injection of tuberculin purified protein derivative

Mohamed Azab0 个研究点目标入组 49 人开始时间: 2020年5月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Male

入选标准

  • male patients complaining of external anogenital warts more than 18 years of age.

排除标准

  • Exclusion Criteria included immuno-compromised patients (HIV, chronic debilitating diseases or malignancy); patients with hemolytic blood diseases patients, patients with active tuberculosis and patient received any other modality for treatment for genital warts during study or in the last 3 months.

研究者

发起方
Mohamed Azab

相似试验